JP2003512841A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003512841A5 JP2003512841A5 JP2001533989A JP2001533989A JP2003512841A5 JP 2003512841 A5 JP2003512841 A5 JP 2003512841A5 JP 2001533989 A JP2001533989 A JP 2001533989A JP 2001533989 A JP2001533989 A JP 2001533989A JP 2003512841 A5 JP2003512841 A5 JP 2003512841A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acids
- polypeptide
- amino acid
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001413 amino acids Chemical class 0.000 description 82
- 229920001184 polypeptide Polymers 0.000 description 45
- 229920000023 polynucleotide Polymers 0.000 description 32
- 239000002157 polynucleotide Substances 0.000 description 32
- 108020004707 nucleic acids Proteins 0.000 description 26
- 150000007523 nucleic acids Chemical class 0.000 description 26
- 239000000203 mixture Substances 0.000 description 22
- 125000003275 alpha amino acid group Chemical group 0.000 description 15
- 210000004027 cells Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 102000004965 antibodies Human genes 0.000 description 7
- 108090001123 antibodies Proteins 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 229920001405 Coding region Polymers 0.000 description 6
- 210000002569 neurons Anatomy 0.000 description 6
- 208000004559 Hearing Loss Diseases 0.000 description 4
- 230000003291 dopaminomimetic Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 108050007372 Fibroblast growth factor family Proteins 0.000 description 3
- 102000018233 Fibroblast growth factor family Human genes 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000001340 slower Effects 0.000 description 3
- 210000004556 Brain Anatomy 0.000 description 2
- 210000003477 Cochlea Anatomy 0.000 description 2
- 101700028871 FGF20 Proteins 0.000 description 2
- 102100007142 FGF20 Human genes 0.000 description 2
- 206010061536 Parkinson's disease Diseases 0.000 description 2
- 230000000295 complement Effects 0.000 description 2
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 102000027757 FGF receptors Human genes 0.000 description 1
- 108091008101 FGF receptors Proteins 0.000 description 1
- 206010019243 Hearing disease Diseases 0.000 description 1
- 206010011879 Hearing loss Diseases 0.000 description 1
- 206010061255 Ischaemia Diseases 0.000 description 1
- 206010027183 Meniere's disease Diseases 0.000 description 1
- 108020004999 Messenger RNA Proteins 0.000 description 1
- 206010033103 Otosclerosis Diseases 0.000 description 1
- 208000004843 Pendred syndrome Diseases 0.000 description 1
- 210000003523 Substantia Nigra Anatomy 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 229920002106 messenger RNA Polymers 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16116299P | 1999-10-22 | 1999-10-22 | |
| US60/161,162 | 1999-10-22 | ||
| US18785600P | 2000-03-08 | 2000-03-08 | |
| US60/187,856 | 2000-03-08 | ||
| PCT/US2000/029237 WO2001031008A2 (en) | 1999-10-22 | 2000-10-20 | Human and rat fgf-20 genes and gene expression products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003512841A JP2003512841A (ja) | 2003-04-08 |
| JP2003512841A5 true JP2003512841A5 (es) | 2007-12-06 |
Family
ID=26857561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001533989A Pending JP2003512841A (ja) | 1999-10-22 | 2000-10-20 | ヒトおよびラットｆｇｆ−２０遺伝子および遺伝子発現産物 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1224283A2 (es) |
| JP (1) | JP2003512841A (es) |
| AU (1) | AU1101901A (es) |
| CA (1) | CA2388637A1 (es) |
| WO (1) | WO2001031008A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056885B1 (en) | 1999-07-27 | 2006-06-06 | Curagen Corporation | Fibroblast growth factor and nucleic acids encoding same |
| US7253266B2 (en) | 1999-07-27 | 2007-08-07 | Curagen Corporation | Polypeptides of FGF-CX |
| WO2001068854A2 (en) * | 2000-03-13 | 2001-09-20 | Amgen, Inc. | Fibroblast growth factor-like molecules and uses thereof |
| GB2365869A (en) * | 2000-05-30 | 2002-02-27 | Smithkline Beecham Corp | SbgFGF-9a polynucleotides and polypeptides |
| WO2001092522A2 (en) * | 2000-06-01 | 2001-12-06 | Eli Lilly And Company | Human fgf-20 nucleic acids and polypeptides |
| AU7181101A (en) * | 2000-07-03 | 2002-01-14 | Curagen Corp | Novel fibroblast growth factors and nucleic acids encoding same |
| US6982250B2 (en) | 2000-11-06 | 2006-01-03 | Curagen Corporation | Methods of prevention and treatment of inflammatory bowel disease |
| US7189693B2 (en) | 2000-11-06 | 2007-03-13 | Curagen Corporation | Treatment of inflammatory bowel disease using fibroblast growth factor CX polypeptides |
| US20020151496A1 (en) * | 2000-12-08 | 2002-10-17 | Bringmann Peter W. | Novel fibroblast growth factors |
| JP2005500035A (ja) * | 2001-06-15 | 2005-01-06 | キュラジェン コーポレイション | 新規線維芽細胞成長因子およびそれをコード化する核酸 |
| WO2004105787A1 (en) * | 2003-05-28 | 2004-12-09 | The University Of Kyoto | Methods of using combinations of egf-2 and egf-20 to treat central nervous system disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1183051A2 (en) * | 1999-03-15 | 2002-03-06 | Chiron Corporation | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| US7056885B1 (en) * | 1999-07-27 | 2006-06-06 | Curagen Corporation | Fibroblast growth factor and nucleic acids encoding same |
-
2000
- 2000-10-20 JP JP2001533989A patent/JP2003512841A/ja active Pending
- 2000-10-20 WO PCT/US2000/029237 patent/WO2001031008A2/en active Application Filing
- 2000-10-20 CA CA002388637A patent/CA2388637A1/en not_active Abandoned
- 2000-10-20 AU AU11019/01A patent/AU1101901A/en not_active Abandoned
- 2000-10-20 EP EP00972344A patent/EP1224283A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003531583A5 (es) | ||
| JP2003516731A5 (es) | ||
| EP2970987B1 (en) | Compositions and methods of altering cholesterol levels | |
| Hanukogle et al. | Complementary DNA sequence of a human cytoplasmic actin: interspecies divergence of 3′ non-coding regions | |
| JP2005341968A5 (es) | ||
| KR20160067219A (ko) | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 | |
| RU2012107671A (ru) | Композиция для лечения инфекции вирусом гепатита в | |
| JP2003512841A5 (es) | ||
| JP2002528060A5 (es) | ||
| EP3076994A2 (en) | Targeted adaptive vaccines | |
| EP3188749A1 (en) | Tolerogenic compositions and methods | |
| HK1167432A1 (zh) | 於阿茲海默氏症治療方法中的應用 | |
| Kiyatkin et al. | Cloning and structural analysis of α‐latroinsectotoxin cDNA: Abundance of ankyrin‐like repeats | |
| JP2004531242A5 (es) | ||
| JP2000512137A (ja) | レプチン（ｏｂタンパク質）のフラグメント | |
| SK38998A3 (en) | Truncated glial cell line-derived neurotrophic factor | |
| JP2001520037A5 (es) | ||
| RU2003130638A (ru) | Протеин, связанный с заболеванием | |
| JP2006502702A5 (es) | ||
| JP2009507474A5 (es) | ||
| JP2002517193A5 (es) | ||
| PT98695A (pt) | Gene codificador do factor neurotrofico de ligacao a heparina | |
| CA2202519A1 (en) | Cloning, expression and characterization of a new form of phosphatidylinositol-3-kinase | |
| JP2002512005A5 (es) | ||
| WO2004035535A2 (en) | Erythrocyte differentiation factor, gene encoding same, and methods of use thereof |